House Bill
H.R. 4106
Prevent Illegal Gun Sales Act
Primary Sponsor
Debbie Dingell
Representative
Cosponsors
2
Quick Stats
Policy Area
Summary
This bill would allow state and tribal governments to use federal opioid response grants to purchase fentanyl and xylazine test strips. These strips help people identify the presence of dangerous substances in drugs, which can prevent overdoses.
Latest Action
Referred to the Subcommittee on Health.
See this page through your district lens
Enter ZIP to personalize representatives and vote context.
Stay on top of this issue
Subscribe for weekly bill and representative updates.
Vote Prediction
Prevent Illegal Gun Sales Act
This bill would allow state and tribal governments to use federal opioid response grants to purchase fentanyl and xylazine test strips. These strips help people identify the presence of dangerous substances in drugs, which can prevent overdoses.
Community Breakdown
Pass
0%
Fail
0%
0 predictions
This bill would allow state and tribal governments to use federal opioid response grants to purchase fentanyl and xylazine test strips. These strips help people identify the presence of dangerous substances in drugs, which can prevent overdoses.
- Bill Number
- 4106
- Sponsor
- Debbie Dingell (D-MI)
- Introduced
- 7/14/2025
- Status
- Referred to the House Committee on the Judiciary.
- Policy Area
- Health
Data from Congress.gov
Fact Sheet
- Title
- Prevent Illegal Gun Sales Act
- Bill Number
- 4106
- Sponsor
- Debbie Dingell (D-MI)
- Status
- Referred to the House Committee on the Judiciary.
- Introduced
- 7/14/2025
- Summary
- This bill would allow state and tribal governments to use federal opioid response grants to purchase fentanyl and xylazine test strips. These strips help people identify the presence of dangerous substances in drugs, which can prevent overdoses.
Data from Congress.gov
Public Opinions
Community submissions related to this bill.
No public opinions yet. Be the first to submit one for this bill.
Related Bills in Health
Empowering Patient Choice of Medical Care Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means
To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
Referred to the House Committee on Energy and Commerce.
Anti-Racism in Public Health Act of 2025
Referred to the House Committee on Energy and Commerce.
SOAR Act of 2025
Read twice and referred to the Committee on Finance.